Hydroxyethyl starch reduces the chemotaxis of white cells through endothelial cell monolayers

Transfusion

Volumn 39, Issue 3, 1999, Pages 289-294

  Hofbauer, Roland ^a   Moser, D ^b   Hornykewycz, S ^b   Frass, M ^b   Kapiotis, S ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; PLASMA SUBSTITUTE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; ENDOTHELIUM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE MIGRATION; LEUKOCYTE MIGRATION INHIBITION; MONOLAYER CULTURE; NEUTROPHIL CHEMOTAXIS; NORMAL HUMAN;

EID: 0033044299     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39399219286.x     Document Type: Article

References (36)

1. Issekutz AC, Chuluyan HE, Lopes N. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms. J Leukoc Biol 1995;57:553-61.
2. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992;14:93-100.
3. Mackay CR, Imhof BA. Cell adhesion in the immune system. Immunol Today 1993;14:99-102.
4. Butcher EC. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 1991;67:1033-9.
5. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
6. Strauss RG, Koepke JA, Maguire LC, Thompson JS. Clinical and laboratory effects on donors of intermittent-flow centrifugation platelet-leukapheresis performed with hydroxyethyl starch and citrate. Clin Lab Haematol 1980;2:1-11.
7. Maguire LC, Strauss RG, Koepke JA, et al. The elimination of hydroxyethyl starch from the blood of donors experiencing single or multiple intermittent-flow centrifugation leukapheresis. Transfusion 1981;21:347-53.
8. Mishler JM, Hester JP, Huestis DW, et al. Dosage and scheduling regimens for erythrocyte-sedimenting macromolecules. J Clin Apheresis 1983;1:130-43.
9. Strauss RG, Villhauer PJ, Imig KM, et al. Selecting the optimal dose of low-molecular-weight hydroxyethyl starch (Pentastarch) for granulocyte collection. Transfusion 1987;27:350-2.
10. Strauss RG, Hester JP, Vogler WR, et al. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors. Transfusion 1986;26:258-64.
11. Strauss RG, Stump DC, Henriksen RA, Saunders R. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation, and fibrinolysis. Transfusion 1985;25:230-4.
12. Stump DC, Strauss RG, Heinriksen RA, et al. Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion 1985;25:349-54.
13. Strauss RG, Snyder EL, Stuber J, Fick RB Jr. Ingestion of hydroxyethyl starch by human leukocytes. Transfusion 1986;26:88-90.
14. Macintyre E, Mackie IJ, Ho D, et al. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Intensive Care Med 1985;11:300-3.
15. Shatney CH, Deepika K, Militello PR, et al. Efficacy of hetastarch in the resuscitation of patients with multisystem trauma and shock. Arch Surg 1983;118:804-9.
16. Rackow EC, Mecher C, Astiz ME, et al. Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion. Crit Care Med 1989;17:394-8.
17. Klose R, Feldmann U, Hoecker P. [Effect of 10% hydroxyethylstarch 200/0.5 and 10% Dextran 40 on the flow property and coagulation of whole blood in vivo] (Engl abstract)]. Infusionsther Klin Ernahr 1987;14 Suppl 2:37-42.
18. Schöndorff T, Weber U, Hempelmann G. Proceedings of haemodilution. Stuttgart: Schattauer, 1987.
19. Sillett HK, Whicher JT, Trejdosiewicz LK. Effects of resuscitation fluids on nonadaptive immune responses. Transfusion 1997;37:953-9.
20. Eastlund DT, Douglas MS, Choper JZ. Monocyte chemotaxis and chemotactic cytokine release after exposure to hydroxyethyl starch. Transfusion 1992;32:855-60.
21. French JE, Solomon JM, Fratantoni JC. Survey on the current use of leukapheresis and the collection of granulocyte concentrates. Transfusion 1982;22:220-5.
22. Schiffer CA, Aisner J, Schmukler M, et al. The effect of hydroxyethyl starch on in vitro platelet and granulocyte function. Transfusion 1975;15:473-5.
23. Sussman LN, Colli W, Pichetshote C. Harvesting of granulocytes using a hydroxyethyl starch solution. Transfusion 1975;15:461-5.
24. Metcalf JA, Gallin JI, Nauseef WM. Preparation of cells and materials for functional assays. New York: Raven Press, 1986.
25. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
26. Piper HM, ed. Cell culture techniques in heart and vessel research. New York: Springer-Verlag, 1990.
27. Treib J, Haass A, Pindur G, et al. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thromb Haemost 1995;74:1452-6.
28. Hofbauer R, Speiser W, Kapiotis S. Ibuprofen inhibits leukocyte migration through endothelial cell monolayers. Life Sci 1998;62:1775-81.
29. Baghesthanian M, Hofbauer R, Kiener HP, et al. The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells. Blood 1997;90:4438-49.
30. Baghesthanian M, Hofbauer R, Kress HG, et al. Thrombin augments vascular cell-dependent migration of human mast cells: role of MGF. Thromb Haemost 1997;77:577-84.
31. Sillaber C, Baghestanian M, Hofbauer R, et al. Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem 1997;272:7824-32.
32. Haugland RP. Fluorescent dyes for assessing vital cell functions. Eugene, OR: Molecular Probes, 1993.
33. Caspar CB, Seger RA, Burger J, Gmur J. Effective stimulation of donors for granulocyte transfusions with recombinant methionyl granulocyte colony-stimulating factor. Blood 1993;81:2866-71.
34. Collis RE, Collins PW, Gutteridge CN, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994;20:37-41.
35. Kapiotis S, Quehenberger P, Sengoelge G, et al. Modulation of pyrogen-induced upregulation of endothelial cell adhesion molecules (CAMs) by interleukin-4: transcriptional mechanisms and CAM-shedding. Circ Shock 1994;43:18-25.
36. Boldt J, Heesen M, Padberg W, et al. The influence of volume therapy and pentoxiphylline infusion on circulating adhesion molecules in trauma patients. Anaesthesia 1996;51:529-35.